Abstract
Purpose of Review: Review building of programs to eliminate Toxoplasma infections. Recent Findings: Morbidity and mortality from toxoplasmosis led to programs in USA, Panama, and Colombia to facilitate understanding, treatment, prevention, and regional resources, incorporating student work. Summary: Studies foundational for building recent, regional approaches/programs are reviewed. Introduction provides an overview/review of programs in Panamá, the United States, and other countries. High prevalence/risk of exposure led to laws mandating testing in gestation, reporting, and development of broad-based teaching materials about Toxoplasma. These were tested for efficacy as learning tools for high-school students, pregnant women, medical students, physicians, scientists, public health officials and general public. Digitized, free, smart phone application effectively taught pregnant women about toxoplasmosis prevention. Perinatal infection care programs, identifying true regional risk factors, and point-of-care gestational screening facilitate prevention and care. When implemented fully across all demographics, such programs present opportunities to save lives, sight, and cognition with considerable spillover benefits for individuals and societies.
Original language | English |
---|---|
Pages (from-to) | 57-92 |
Number of pages | 36 |
Journal | Current Pediatrics Reports |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2022 |
Externally published | Yes |
Keywords
- Brazil
- Colombia
- France
- Morocco
- Panama
- United States
- congenital toxoplasmosis
- foundational work
- medical care
- public health
- pyrimethamine
- review
- student research
- sulfadiazine
- toxoplasmosis
Access to Document
Fingerprint
Dive into the research topics of 'Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Building Programs to Eradicate Toxoplasmosis Part I : Introduction and Overview. / Felín, Mariangela Soberón; Wang, Kanix; Moreira, Aliya et al.
In: Current Pediatrics Reports, Vol. 10, No. 3, 09.2022, p. 57-92.Research output: Contribution to journal › Review article › peer-review
TY - JOUR
T1 - Building Programs to Eradicate Toxoplasmosis Part I
T2 - Introduction and Overview
AU - Felín, Mariangela Soberón
AU - Wang, Kanix
AU - Moreira, Aliya
AU - Grose, Andrew
AU - Leahy, Karen
AU - Zhou, Ying
AU - Clouser, Fatima Alibana
AU - Siddiqui, Maryam
AU - Leong, Nicole
AU - Goodall, Perpetua
AU - Michalowski, Morgan
AU - Ismail, Mahmoud
AU - Christmas, Monica
AU - Schrantz, Stephen
AU - Caballero, Zuleima
AU - Norero, Ximena
AU - Estripeaut, Dora
AU - Ellis, David
AU - Raggi, Catalina
AU - Castro, Catherine
AU - Moossazadeh, Davina
AU - Ramirez, Margarita
AU - Pandey, Abhinav
AU - Ashi, Kevin
AU - Dovgin, Samantha
AU - Dixon, Ashtyn
AU - Li, Xuan
AU - Begeman, Ian
AU - Heichman, Sharon
AU - Lykins, Joseph
AU - Villalobos-Cerrud, Delba
AU - Fabrega, Lorena
AU - Montalvo, José Luis Sanchez
AU - Mendivil, Connie
AU - Quijada, Mario R.
AU - Fernández-Pirla, Silvia
AU - de La Guardia, Valli
AU - Wong, Digna
AU - de Guevara, Mayrene Ladrón
AU - Flores, Carlos
AU - Borace, Jovanna
AU - García, Anabel
AU - Caballero, Natividad
AU - Rengifo-Herrera, Claudia
AU - de Saez, Maria Theresa Moreno
AU - Politis, Michael
AU - Wroblewski, Kristen
AU - Karrison, Theodore
AU - Ross, Stephanie
AU - Dogra, Mimansa
AU - Dhamsania, Vishan
AU - Graves, Nicholas
AU - Kirchberg, Marci
AU - Mathur, Kopal
AU - Aue, Ashley
AU - Restrepo, Carlos M.
AU - Llanes, Alejandro
AU - Guzman, German
AU - Rebellon, Arturo
AU - Boyer, Kenneth
AU - Heydemann, Peter
AU - Noble, A. Gwendolyn
AU - Swisher, Charles
AU - Rabiah, Peter
AU - Withers, Shawn
AU - Hull, Teri
AU - Su, Chunlei
AU - Blair, Michael
AU - Latkany, Paul
AU - Mui, Ernest
AU - Vasconcelos-Santos, Daniel Vitor
AU - Villareal, Alcibiades
AU - Perez, Ambar
AU - Galvis, Carlos Andrés Naranjo
AU - Montes, Mónica Vargas
AU - Perez, Nestor Ivan Cardona
AU - Ramirez, Morgan
AU - Chittenden, Cy
AU - Wang, Edward
AU - Garcia-López, Laura Lorena
AU - Muñoz-Ortiz, Juliana
AU - Rivera-Valdivia, Nicolás
AU - Bohorquez-Granados, María Cristina
AU - de-la-Torre, Gabriela Castaño
AU - Padrieu, Guillermo
AU - Hernandez, Juan David Valencia
AU - Celis-Giraldo, Daniel
AU - Dávila, Juan Alejandro Acosta
AU - Torres, Elizabeth
AU - Oquendo, Manuela Mejia
AU - Arteaga-Rivera, José Y.
AU - Nicolae, Dan L.
AU - Rzhetsky, Andrey
AU - Roizen, Nancy
AU - Stillwaggon, Eileen
AU - Sawers, Larry
AU - Peyron, Francois
AU - Wallon, Martine
AU - Chapey, Emanuelle
AU - Levigne, Pauline
AU - Charter, Carmen
AU - De Frias, Migdalia
AU - Montoya, Jose
AU - Press, Cindy
AU - Ramirez, Raymund
AU - Contopoulos-Ioannidis, Despina
AU - Maldonado, Yvonne
AU - Liesenfeld, Oliver
AU - Gomez, Carlos
AU - Wheeler, Kelsey
AU - Holfels, Ellen
AU - Frim, David
AU - McLone, David
AU - Penn, Richard
AU - Cohen, William
AU - Zehar, Samantha
AU - McAuley, James
AU - Limonne, Denis
AU - Houze, Sandrine
AU - Abraham, Sylvie
AU - Piarroux, Raphael
AU - Tesic, Vera
AU - Beavis, Kathleen
AU - Abeleda, Ana
AU - Sautter, Mari
AU - El Mansouri, Bouchra
AU - El Bachir, Adlaoui
AU - Amarir, Fatima
AU - El Bissati, Kamal
AU - de-la-Torre, Alejandra
AU - Britton, Gabrielle
AU - Motta, Jorge
AU - Ortega-Barria, Eduardo
AU - Romero, Isabel Luz
AU - Meier, Paul
AU - Grigg, Michael
AU - Gómez-Marín, Jorge
AU - Kosagisharaf, Jagannatha Rao
AU - Llorens, Xavier Sáez
AU - Reyes, Osvaldo
AU - McLeod, Rima
N1 - Funding Information: We gratefully acknowledge the following organizations and people for their financial, logistical, and/or technical support during our work on this project. Panama: Thanks to the Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT), the Sistema Nacional de Investigación (SNI), the Institute for Scientific Research and High Technology Services of Panama (INDICASAT), Hospital del Niño, Hospital Santo Tomás, and Roche Diagnostics International Ltd. Special thanks to the medical staff of the high-risk pregnancy and infectious disease wings of Hospital Santo Tomás, especially Aris Caballero de Mendieta, Susana Frías, Dario Beneditto, Edwin Ortiz, Carlos Moreno, Ana Belen Arauz, Monica Pachar, Eyra Garcia, as well as to the nurses for all their logistical support. We thank little Henry Arosemena, who was the impetus for starting the program in Panama, and the Arosemena family for their support of educational initiatives in Panama. Colombia: Thanks to the Grupo de Investigación en Parasitología Molecular (GEPAMOL) at the University of Quindío, to Richard James Orozco González, and to Hospital del Sur and Hospital San Juan de Dios in Armenia, Colombia. United States: Thanks to Dr. Brian Callender, Dr. Jeanne Farnan, Dr. Olofunmilayo Olopade, Absera Melaku, MPH, Kristyna Hulland, MS, Dr. Susan Duncan, and Dr. John Schneider for facilitating summer research through the Summer Research Program at the Pritzker School of Medicine at the University of Chicago. We appreciate Aaron Ponsler’s suggestion at a Thrasher Foundation site visit at Stanford University that the LDBio could do the most good if it were cleared by the FDA and waived by CLIA. We thank all those in the National Collaborative Chicago-Based Congenital Toxoplasmosis Study (NCCCTS) who helped build and sustain programs in the United States. We especially thank the many families who participated in and/or encouraged these initiatives, and their primary care physicians. We give special thanks to these participant families and their physicians without whom this NCCCTS could not have been performed. We thank all those who traveled to Springfield IL to begin gestational screening in the United States, recognizing the importance this would have had for their families. We thank those who worked with the NCCCTS in the earlier years including Marilyn Mets, William Mieler, Michael Grassi, Michael Kip, Hassan Shah, Diane Patton, Vicky Aithchison, Holly McGinnis, Randee Estes, Douglas Mack, Michael Kirisits, Adrian Esquivel, Toria Trendler, Joseph MCammon, Simone Cezar, Jessica Coyne, Daniel Lee, Diana Chamot, Jane Babiarz, Veena Arun, Laura Phan, as well as Daniel Johnson, Adil Javed and others as reflected in the author lists in references 3-50. Their contributions to the initial phases of this work were substantial and valuable. We thank additional authors and members of the NCCCTS group Barbara Danis, Mark Stein, Linda Pfiffner, Jeanne Perkins, Sanford Meyers, Balaji Gupta, Ahmed Abdelsalam, Huiyuan Zhang, John Marcinak, Saeid Mojatahedi, Dianna Bardo, Marisha Humphries, Douglas Mack, Michael J. Kirisits, Diana Chamot, Ronald Thisted, Carina Yang, Delilah Burrowes, and John Collins (University of Chicago, Chicago, IL); Lazlo Stein (Northwestern University, Chicago; deceased); Andrew Suth (Argosy University, Chicago); Audrey Cameron (Mount Sinai Hospital, Chicago); Marie Weissbourd (Northwestern University Hospital, Chicago); Joyce Hopkins (Illinois Institute of Technology, Chicago); Dushyant Patel (Michael Reese Medical Center, Chicago); and others. We thank Jack Remington and those in the Remington serology laboratory who performed the serologic testing for participants in the NCCCTS establishing the diagnosis for each participant as part of their clinical care, allowing the NCCCTS to be based on rigorous, meticulous diagnostic criteria. We thank the Data Safety Monitoring Board members, John Flagherty, Richard Chappell, David Mittelmam, Dana Bradzunias. We thank those working with us to establish gestational screening for perinatal infections and to develop and test WHO-compatible POC tests in the United States, France, and Morocco, Mohamed Rhajaoui, Amina Barkat, Hua Cong, and Bo Shiun Lai. Additionally, we thank Shaun Carey, James Lynch, Millie Malekar, others in the IRB office, Jim Rago and Sam Campbell for photography, David G Goodwin, Colin Shephard, Ribhi M. Shawar, Matthew Macgilvray, and Steven Gitterman for their guidance with FDA processes, NIH DMID Program, Officers Michael Gottlieb, F. Lee Hall, Stephanie James, and John Rogers for many suggestions, Jean Hickman for assistance, additional Morocco Group colleagues including Mohamed Rhajaoui working alongside and with us, for their help and support in implementing prenatal screening for toxoplasmosis in Morocco. We thank Iris Ramirez for her contribution to screening. We thank Tom Lint for assistance with many aspects of the study. France/Austria: Many thanks to our French and Austrian colleagues, who paved the way and worked with us in understanding the importance of prompt gestational screening, treatment, and prevention of congenital toxoplasmosis. Funding Information: Additional thanks for funding from the Jeff Metcalf Internship Program, the Margaret P Thorp Scholarship Fund, the American College of Obstetricians and Gynecologists for their Medical Student Award, the National Institute of Diabetes and Digestive and Kidney Diseases for their Grant #T35DK062719-30, the American Society of Tropical Medicine and Hygiene for their Benjamin H. Kean Fellowship, the National Institutes of Health for their Division of Microbiology and Infectious Diseases Grants to RMc #R01 AI2753,RO1 16945, AI08749-01A1 BIOL-3 , U01 AI77887, U01 AI082180, TMP R01-AI071319, the Thrasher Research Fund for their E.W. “Al” Thrasher Award, the Kiphardt Global-Local Health Seed Fund Award of the University of Chicago, SENACYT, the Research to Prevent Blindness Foundation, March of Dimes (6-528), the FDA , the Pillsbury Foundation, Michael Reese, Physicians Research and Education Foundation, the Fulbright Scholar Awards (Craig Roberts, Kamal ElBissati, Dorota Nowakowska), the Pathological Society of Great Britain and Northern Ireland Travel Award, (Fiona Roberts) the WHO DIF, and the Stanley Foundation. This work was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH (Michael Grigg). Publisher Copyright: © 2022, The Author(s).
PY - 2022/9
Y1 - 2022/9
N2 - Purpose of Review: Review building of programs to eliminate Toxoplasma infections. Recent Findings: Morbidity and mortality from toxoplasmosis led to programs in USA, Panama, and Colombia to facilitate understanding, treatment, prevention, and regional resources, incorporating student work. Summary: Studies foundational for building recent, regional approaches/programs are reviewed. Introduction provides an overview/review of programs in Panamá, the United States, and other countries. High prevalence/risk of exposure led to laws mandating testing in gestation, reporting, and development of broad-based teaching materials about Toxoplasma. These were tested for efficacy as learning tools for high-school students, pregnant women, medical students, physicians, scientists, public health officials and general public. Digitized, free, smart phone application effectively taught pregnant women about toxoplasmosis prevention. Perinatal infection care programs, identifying true regional risk factors, and point-of-care gestational screening facilitate prevention and care. When implemented fully across all demographics, such programs present opportunities to save lives, sight, and cognition with considerable spillover benefits for individuals and societies.
AB - Purpose of Review: Review building of programs to eliminate Toxoplasma infections. Recent Findings: Morbidity and mortality from toxoplasmosis led to programs in USA, Panama, and Colombia to facilitate understanding, treatment, prevention, and regional resources, incorporating student work. Summary: Studies foundational for building recent, regional approaches/programs are reviewed. Introduction provides an overview/review of programs in Panamá, the United States, and other countries. High prevalence/risk of exposure led to laws mandating testing in gestation, reporting, and development of broad-based teaching materials about Toxoplasma. These were tested for efficacy as learning tools for high-school students, pregnant women, medical students, physicians, scientists, public health officials and general public. Digitized, free, smart phone application effectively taught pregnant women about toxoplasmosis prevention. Perinatal infection care programs, identifying true regional risk factors, and point-of-care gestational screening facilitate prevention and care. When implemented fully across all demographics, such programs present opportunities to save lives, sight, and cognition with considerable spillover benefits for individuals and societies.
KW - Brazil
KW - Colombia
KW - France
KW - Morocco
KW - Panama
KW - United States
KW - congenital toxoplasmosis
KW - foundational work
KW - medical care
KW - public health
KW - pyrimethamine
KW - review
KW - student research
KW - sulfadiazine
KW - toxoplasmosis
UR - http://www.scopus.com/inward/record.url?scp=85136932892&partnerID=8YFLogxK
U2 - 10.1007/s40124-022-00269-w
DO - 10.1007/s40124-022-00269-w
M3 - Review article
AN - SCOPUS:85136932892
VL - 10
SP - 57
EP - 92
JO - Current Pediatrics Reports
JF - Current Pediatrics Reports
SN - 2167-4841
IS - 3
ER -